UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Policy and perspective on outpatient programs for autologous hematopoietic cell transplantation and immune-effector cell therapy administration

Frontiers in immunology, 2024-08, Vol.15, p.1423959

2024

Volltextzugriff (PDF)

Hematopoeitic Cell Transplantation and CAR T-Cell Therapy: Complements or Competitors?

Frontiers in oncology, 2020-12, Vol.10, p.608916

2020

Volltextzugriff (PDF)

Cytomegalovirus viremia, disease, and impact on relapse in T-cell replete peripheral blood haploidentical hematopoietic cell transplantation with post-transplant cyclophosphamide

Haematologica (Roma), 2016-11, Vol.101 (11), p.e465-e468

2016

Volltextzugriff (PDF)

Resolution of secondary hemophagocytic lymphohistiocytosis after treatment with the JAK1/2 inhibitor ruxolitinib

Blood advances, 2019-12, Vol.3 (23), p.4131-4135

2019

Volltextzugriff (PDF)

What Do the Elevated Protein Levels Mean in My Patients with Myeloma, Amyloidosis, and Related Disorders?

The American journal of medicine, 2022-04, Vol.135, p.S24-S29

2022

Volltextzugriff (PDF)

Selinexor therapy for multiple myeloma and non-Hodgkin lymphomas

Current opinion in oncology, 2022-09, Vol.34 (5), p.524-530

2022

Volltextzugriff (PDF)

Bispecific Antibodies for the Treatment of Multiple Myeloma

Current hematologic malignancy reports, 2022-12, Vol.17 (6), p.286-297

2022

Volltextzugriff (PDF)

A phase Ib trial of isatuximab, bendamustine, and prednisone in relapsed/refractory multiple myeloma

Annals of hematology, 2024-09

2024

Volltextzugriff (PDF)

Evolving Paradigms of Therapy for Multiple Myeloma: State of the Art and Future Directions

JCO oncology practice, 2021-07, Vol.17 (7), p.415-418

2021

Volltextzugriff (PDF)

Single-Cell Discovery and Multiomic Characterization of Therapeutic Targets in Multiple Myeloma

Cancer research (Chicago, Ill.), 2023-04, Vol.83 (8), p.1214-1233

2023

Volltextzugriff (PDF)

DCEP and bendamustine/prednisone as salvage therapy for quad- and penta-refractory multiple myeloma

Annals of hematology, 2020-05, Vol.99 (5), p.1041-1048

2020

Volltextzugriff (PDF)

Chimeric Antigen Receptor T Cell Therapy versus Hematopoietic Stem Cell Transplantation: An Evolving Perspective

Transplantation and cellular therapy, 2022-11, Vol.28 (11), p.727-736

2022

Volltextzugriff (PDF)

Autologous stem cell transplant for patients with multiple myeloma between ages 75 and 78

Bone marrow transplantation (Basingstoke), 2021-08, Vol.56 (8), p.2016-2018

2021

Volltextzugriff (PDF)

Next Generation Sequencing-based Validation of the Revised International Staging System for Multiple Myeloma: An Analysis of the MMRF CoMMpass Study

Clinical lymphoma, myeloma and leukemia, 2019-05, Vol.19 (5), p.285-289

2019

Volltextzugriff (PDF)

EZH2 Overexpression in Multiple Myeloma: Prognostic Value, Correlation With Clinical Characteristics, and Possible Mechanisms

Clinical lymphoma, myeloma and leukemia, 2019-11, Vol.19 (11), p.744-750

2019

Volltextzugriff (PDF)

Duvelisib for Critically Ill Patients With Coronavirus Disease 2019: An Investigator-Initiated, Randomized, Placebo-Controlled, Double-Blind Pilot Trial

Open forum infectious diseases, 2023-11, Vol.10 (11), p.ofad518-ofad518

2023

Volltextzugriff (PDF)

Clonal Hematopoiesis is Associated With Severe Cytokine Release Syndrome in Patients Treated With Chimeric Antigen Receptor T-Cell (CART) Therapy

Transplantation and cellular therapy, 2024-09, Vol.30 (9), p.927.e1-927.e9

2024

Volltextzugriff (PDF)

Newly Diagnosed Myeloma in 2020

American Society of Clinical Oncology educational book, 2020-03, Vol.40 (40), p.1-e158

2020

Volltextzugriff (PDF)

Immunoglobulin Variable Heavy Chain Somatic Hypermutation Testing in a Patient with Small Lymphocytic Lymphoma and Multiple Myeloma

The journal of applied laboratory medicine, 2021-11, Vol.6 (6), p.1665-1670

2021

Volltextzugriff (PDF)

15. Single-cell discovery and multi-omic characterization of therapeutic targets in multiple myeloma

Journal of bone oncology, 2024-04, Vol.45, p.100553, Article 100553

2024

Volltextzugriff (PDF)

Abstract 716: Telehealth use among multiple myeloma patients during the COVID-19 pandemic

Cancer research (Chicago, Ill.), 2021-07, Vol.81 (13_Supplement), p.716-716

2021

Volltextzugriff (PDF)

Impact of Health Insurance and Access to Autologous Stem Cell Transplantation (ASCT) on Racial Inequity in Overall Survival (OS) Among Patients with Multiple Myeloma (MM)

Blood, 2023-11, Vol.142 (Supplement 1), p.4730-4730

2023

Volltextzugriff (PDF)

1 – 25 von 163

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(145)
Mit Volltextzugriff
(142)

Publikationsform

Sprache

Englisch
(163)
Japanisch
(12)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Policy and perspective on outpatient programs for autologous hematopoietic cell transplantation and immune-effector cell therapy administration

Hematopoeitic Cell Transplantation and CAR T-Cell Therapy: Complements or Competitors?

Cytomegalovirus viremia, disease, and impact on relapse in T-cell replete peripheral blood haploidentical hematopoietic cell transplantation with post-transplant cyclophosphamide

Resolution of secondary hemophagocytic lymphohistiocytosis after treatment with the JAK1/2 inhibitor ruxolitinib

What Do the Elevated Protein Levels Mean in My Patients with Myeloma, Amyloidosis, and Related Disorders?

Selinexor therapy for multiple myeloma and non-Hodgkin lymphomas

Posttransplant cyclophosphamide is associated with increased cytomegalovirus infection: a CIBMTR analysis

Bispecific Antibodies for the Treatment of Multiple Myeloma

A phase Ib trial of isatuximab, bendamustine, and prednisone in relapsed/refractory multiple myeloma

Evolving Paradigms of Therapy for Multiple Myeloma: State of the Art and Future Directions

Single-Cell Discovery and Multiomic Characterization of Therapeutic Targets in Multiple Myeloma

Incidence and impact of community respiratory viral infections in post‐transplant cyclophosphamide‐based graft‐versus‐host disease prophylaxis and haploidentical stem cell transplantation

DCEP and bendamustine/prednisone as salvage therapy for quad- and penta-refractory multiple myeloma

Chimeric Antigen Receptor T Cell Therapy versus Hematopoietic Stem Cell Transplantation: An Evolving Perspective

Autologous stem cell transplant for patients with multiple myeloma between ages 75 and 78

Next Generation Sequencing-based Validation of the Revised International Staging System for Multiple Myeloma: An Analysis of the MMRF CoMMpass Study

EZH2 Overexpression in Multiple Myeloma: Prognostic Value, Correlation With Clinical Characteristics, and Possible Mechanisms

Duvelisib for Critically Ill Patients With Coronavirus Disease 2019: An Investigator-Initiated, Randomized, Placebo-Controlled, Double-Blind Pilot Trial

Clonal Hematopoiesis is Associated With Severe Cytokine Release Syndrome in Patients Treated With Chimeric Antigen Receptor T-Cell (CART) Therapy

Post-Transplantation Cyclophosphamide Is Associated with an Increase in Non-Cytomegalovirus Herpesvirus Infections in Patients with Acute Leukemia and Myelodysplastic Syndrome

Newly Diagnosed Myeloma in 2020

Immunoglobulin Variable Heavy Chain Somatic Hypermutation Testing in a Patient with Small Lymphocytic Lymphoma and Multiple Myeloma

15. Single-cell discovery and multi-omic characterization of therapeutic targets in multiple myeloma

Abstract 716: Telehealth use among multiple myeloma patients during the COVID-19 pandemic

Impact of Health Insurance and Access to Autologous Stem Cell Transplantation (ASCT) on Racial Inequity in Overall Survival (OS) Among Patients with Multiple Myeloma (MM)

Suchergebnisse filtern